Identification of ANC-3 as a Novel Therapeutic Candidate for Anaplastic Thyroid Cancer Through Drug Screening and Multi-Platform Validation.

Tsagaankhuu D, Baek H, Choi J, Kwon S.

Open source

DOI
10.3390/ijms27125222
Published
2026-06-09
Container
Int J Mol Sci
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms27125222,
  title = {Identification of ANC-3 as a Novel Therapeutic Candidate for Anaplastic Thyroid Cancer Through Drug Screening and Multi-Platform Validation.},
  author = {Tsagaankhuu D and  Baek H and  Choi J and  Kwon S.},
  year = {2026},
  journal = {Int J Mol Sci},
  doi = {10.3390/ijms27125222},
  url = {https://doi.org/10.3390/ijms27125222}
}

RIS

TY  - JOUR
TI  - Identification of ANC-3 as a Novel Therapeutic Candidate for Anaplastic Thyroid Cancer Through Drug Screening and Multi-Platform Validation.
AU  - Tsagaankhuu D
AU  -  Baek H
AU  -  Choi J
AU  -  Kwon S.
PY  - 2026
JO  - Int J Mol Sci
DO  - 10.3390/ijms27125222
UR  - https://doi.org/10.3390/ijms27125222
ER  - 

APA

D, T., H, B., J, C., & S., K. (2026). Identification of ANC-3 as a Novel Therapeutic Candidate for Anaplastic Thyroid Cancer Through Drug Screening and Multi-Platform Validation.. Int J Mol Sci. https://doi.org/10.3390/ijms27125222

Source records